855 related articles for article (PubMed ID: 25839159)
41. Human eukaryotic translation initiation factor 4G (eIF4G) recruits mnk1 to phosphorylate eIF4E.
Pyronnet S; Imataka H; Gingras AC; Fukunaga R; Hunter T; Sonenberg N
EMBO J; 1999 Jan; 18(1):270-9. PubMed ID: 9878069
[TBL] [Abstract][Full Text] [Related]
42. Requirement of the eukaryotic translation initiation factor 4F complex in hepatitis E virus replication.
Zhou X; Xu L; Wang Y; Wang W; Sprengers D; Metselaar HJ; Peppelenbosch MP; Pan Q
Antiviral Res; 2015 Dec; 124():11-9. PubMed ID: 26526587
[TBL] [Abstract][Full Text] [Related]
43. Biophysical studies of eIF4E cap-binding protein: recognition of mRNA 5' cap structure and synthetic fragments of eIF4G and 4E-BP1 proteins.
Niedzwiecka A; Marcotrigiano J; Stepinski J; Jankowska-Anyszka M; Wyslouch-Cieszynska A; Dadlez M; Gingras AC; Mak P; Darzynkiewicz E; Sonenberg N; Burley SK; Stolarski R
J Mol Biol; 2002 Jun; 319(3):615-35. PubMed ID: 12054859
[TBL] [Abstract][Full Text] [Related]
44. Monitoring flux in signalling pathways through measurements of 4EBP1-mediated eIF4F complex assembly.
Frosi Y; Usher R; Lian DTG; Lane DP; Brown CJ
BMC Biol; 2019 May; 17(1):40. PubMed ID: 31118010
[TBL] [Abstract][Full Text] [Related]
45. Activation of the translational suppressor 4E-BP1 following infection with encephalomyocarditis virus and poliovirus.
Gingras AC; Svitkin Y; Belsham GJ; Pause A; Sonenberg N
Proc Natl Acad Sci U S A; 1996 May; 93(11):5578-83. PubMed ID: 8643618
[TBL] [Abstract][Full Text] [Related]
46. RNA-tethering assay and eIF4G:eIF4A obligate dimer design uncovers multiple eIF4F functional complexes.
Robert F; Cencic R; Cai R; Schmeing TM; Pelletier J
Nucleic Acids Res; 2020 Sep; 48(15):8562-8575. PubMed ID: 32749456
[TBL] [Abstract][Full Text] [Related]
47. Activity of the hepatitis A virus IRES requires association between the cap-binding translation initiation factor (eIF4E) and eIF4G.
Ali IK; McKendrick L; Morley SJ; Jackson RJ
J Virol; 2001 Sep; 75(17):7854-63. PubMed ID: 11483729
[TBL] [Abstract][Full Text] [Related]
48. Lack of compensatory pAKT activation and eIF4E phosphorylation of lymphoma cells towards mTOR inhibitor, RAD001.
Kuo SH; Hsu CH; Chen LT; Lu YS; Lin CH; Yeh PY; Jeng HJ; Gao M; Yeh KH; Cheng AL
Eur J Cancer; 2011 May; 47(8):1244-57. PubMed ID: 21334199
[TBL] [Abstract][Full Text] [Related]
49. Eukaryotic translation initiation factor 4E availability controls the switch between cap-dependent and internal ribosomal entry site-mediated translation.
Svitkin YV; Herdy B; Costa-Mattioli M; Gingras AC; Raught B; Sonenberg N
Mol Cell Biol; 2005 Dec; 25(23):10556-65. PubMed ID: 16287867
[TBL] [Abstract][Full Text] [Related]
50. eIF4E/4E-BP ratio predicts the efficacy of mTOR targeted therapies.
Alain T; Morita M; Fonseca BD; Yanagiya A; Siddiqui N; Bhat M; Zammit D; Marcus V; Metrakos P; Voyer LA; Gandin V; Liu Y; Topisirovic I; Sonenberg N
Cancer Res; 2012 Dec; 72(24):6468-76. PubMed ID: 23100465
[TBL] [Abstract][Full Text] [Related]
51. Control of the MYC-eIF4E axis plus mTOR inhibitor treatment in small cell lung cancer.
Matsumoto M; Seike M; Noro R; Soeno C; Sugano T; Takeuchi S; Miyanaga A; Kitamura K; Kubota K; Gemma A
BMC Cancer; 2015 Apr; 15():241. PubMed ID: 25884680
[TBL] [Abstract][Full Text] [Related]
52. The 3' cap-independent translation element of Barley yellow dwarf virus binds eIF4F via the eIF4G subunit to initiate translation.
Treder K; Kneller EL; Allen EM; Wang Z; Browning KS; Miller WA
RNA; 2008 Jan; 14(1):134-47. PubMed ID: 18025255
[TBL] [Abstract][Full Text] [Related]
53. Dual modulation of Ras-Mnk and PI3K-AKT-mTOR pathways: A Novel c-FLIP inhibitory mechanism of 3-AWA mediated translational attenuation through dephosphorylation of eIF4E.
ur Rasool R; Rah B; Amin H; Nayak D; Chakraborty S; Rawoof A; Mintoo MJ; Yousuf K; Mukherjee D; Kumar LD; Mondhe DM; Goswami A
Sci Rep; 2016 Jan; 6():18800. PubMed ID: 26728896
[TBL] [Abstract][Full Text] [Related]
54. PI3K-targeted therapy can be evaded by gene amplification along the MYC-eukaryotic translation initiation factor 4E (eIF4E) axis.
Ilic N; Utermark T; Widlund HR; Roberts TM
Proc Natl Acad Sci U S A; 2011 Sep; 108(37):E699-708. PubMed ID: 21876152
[TBL] [Abstract][Full Text] [Related]
55. Stabilization of eukaryotic initiation factor 4E binding to the mRNA 5'-Cap by domains of eIF4G.
von Der Haar T; Ball PD; McCarthy JE
J Biol Chem; 2000 Sep; 275(39):30551-5. PubMed ID: 10887196
[TBL] [Abstract][Full Text] [Related]
56. The pioneer translation initiation complex is functionally distinct from but structurally overlaps with the steady-state translation initiation complex.
Chiu SY; Lejeune F; Ranganathan AC; Maquat LE
Genes Dev; 2004 Apr; 18(7):745-54. PubMed ID: 15059963
[TBL] [Abstract][Full Text] [Related]
57. Nitric oxide mediates NMDA-induced persistent inhibition of protein synthesis through dephosphorylation of eukaryotic initiation factor 4E-binding protein 1 and eukaryotic initiation factor 4G proteolysis.
Petegnief V; Font-Nieves M; MartÃn ME; Salinas M; Planas AM
Biochem J; 2008 May; 411(3):667-77. PubMed ID: 18215131
[TBL] [Abstract][Full Text] [Related]
58. Eukaryotic translation initiation factor 4F architectural alterations accompany translation initiation factor redistribution in poxvirus-infected cells.
Walsh D; Arias C; Perez C; Halladin D; Escandon M; Ueda T; Watanabe-Fukunaga R; Fukunaga R; Mohr I
Mol Cell Biol; 2008 Apr; 28(8):2648-58. PubMed ID: 18250159
[TBL] [Abstract][Full Text] [Related]
59. Human eukaryotic initiation factor 4E (eIF4E) and the nucleotide-bound state of eIF4A regulate eIF4F binding to RNA.
Izidoro MS; Sokabe M; Villa N; Merrick WC; Fraser CS
J Biol Chem; 2022 Oct; 298(10):102368. PubMed ID: 35963437
[TBL] [Abstract][Full Text] [Related]
60. Sepsis-induced suppression of skeletal muscle translation initiation mediated by tumor necrosis factor alpha.
Lang CH; Frost RA
Metabolism; 2007 Jan; 56(1):49-57. PubMed ID: 17161226
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
